Abstract:ObjectivesLung adenocarcinoma shows broad spectrum of prognosis and histologic heterogeneity. This study was to investigate the prognostic value of CT radiomics in resectable lung adenocarcinoma patients and assess its incremental value over clinical-pathologic risk factors.MethodsThis retrospective analysis evaluated 1058 patients who underwent curative surgery for lung adenocarcinoma (training cohort: N = 754; temporal validation cohort: N = 304). Radiomics features were extracted from preoperative contrast-enhanced CT. Radiomics signature to predict disease-free survival (DFS) and overall survival (OS) was generated. Association between the radiomics signature and prognosis were evaluated using univariable and multivariable Cox proportional hazards regression analyses. Incremental value of the radiomics signature beyond clinical-pathologic risk factors was assessed using concordance index (C-index).ResultsThe radiomics signatures were independently associated with DFS (hazard ratio [HR], 1.920; p < 0.001) and OS (HR, 2.079; p < 0.001). The radiomics signature showed performance comparable to stage in estimation of DFS (C-index, 0.724 vs 0.685) and OS (0.735 vs 0.703). The radiomics added prognostic value to clinical-pathologic models (stage and histologic subtype) in predicting DFS (C-index, 0.764 vs 0.713; p < 0.001), which was also shown in the validation cohort (0.782 vs 0.734; p = 0.016). In terms of OS, including radiomics led to significant improvement in prognostic performance of the clinical-pathologic model (stage and age) in the training cohort (0.784 vs 0.737; p < 0.001), but the improvement was not significant in the validation cohort (0.805 vs 0.734; p = 0.149).ConclusionsCT radiomics was effective in predicting prognosis in lung adenocarcinoma patients, providing additional prognostic information beyond clinical-pathologic risk factors.Key Points• CT radiomics signature was an independent prognostic factor predicting disease-free and overall survival along with clinical risk factors of lung adenocarcinoma (stage, histologic subtype, and age).• CT radiomics added prognostic value to clinical-pathologic models (stage and subtype) in predicting disease-free survival (C-index for integrated model and clinical-pathologic model, 0.764 vs 0.713; p < 0.001), which was also proven in the validation cohort (0.782 vs 0.734; p = 0.016).• Integrated model incorporating radiomics signature can successfully stratify patients into high-risk, intermediate-, or low-risk groups in patients with resectable lung adenocarcinoma.

Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors

Machine Learning Methods Based on CT Features Differentiate G1/G2 from G3 Pancreatic Neuroendocrine Tumors.

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

CT Radiomics May Predict the Grade of Pancreatic Neuroendocrine Tumors: a Multicenter Study

CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor

A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.

Pancreatic Neuroendocrine Tumor: Prediction of Tumor Grades by Radiomics Models Based on Ultrasound Images

Building CT Radiomics-Based Models for Preoperatively Predicting Malignant Potential and Mitotic Count of Gastrointestinal Stromal Tumors

Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.

Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT

The Prognostic Value of Multidetector CT Features in Predicting Overall Survival Outcomes in Patients with Pancreatic Neuroendocrine Tumors.

Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging

Development and validation of CT-based radiomics deep learning signatures to predict lymph node metastasis in non-functional pancreatic neuroendocrine tumors: a multicohort study

Predicting Postoperative Prognosis of Pancreatic Cancer Using a CT-Based Radio-Clinical Model: Exploring Biological Functions

Radiomics machine learning algorithm facilitates detection of small pancreatic neuroendocrine tumors on CT

Pancreatic Cancer: Assessment of Neoadjuvant Chemotherapy Outcome Based on Radiomics of Pretreatment Computed Tomography.

Special Issue "the Advance of Solid Tumor Research in China": Prediction of Sunitinib Efficacy Using Computed Tomography in Patients with Pancreatic Neuroendocrine Tumors.

Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma

Exploring the biological basis of CT imaging features in pancreatic neuroendocrine tumors: a two-center study